Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve

Vaccine

Volumn 28, Issue 11, 2010, Pages 2318-2322

  Cox, Sarah J ^a   Veronica Carr, B ^a   Parida, Satya ^a   Hamblin, Pip A ^a   Prentice, Helen ^a   Charleston, Bryan ^a   Paton, David J ^a   Barnett, Paul V ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Duration; FMD vaccination; Protective immunity

Indexed keywords

AFTOPUR; FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BULLOCK; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EMERGENCY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; LONGEVITY; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; SEROTYPE; UNITED KINGDOM; VIREMIA; VIRUS ISOLATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; FOOT-AND-MOUTH DISEASE; GREAT BRITAIN; IMMUNIZATION, SECONDARY; LYMPHOCYTES; SURVIVAL ANALYSIS; TIME FACTORS; VIRAL VACCINES;

EID: 77049103785     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.065     Document Type: Article

References (21)

1. Barteling S.J., and Vreeswijk J. Developments in foot-and-mouth vaccines (review). Vaccine 9 (1991) 75-88
2. Doel T.R. Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. Rev Sci Tech Off Int Epiz 15 3 (1996) 883-911
3. Doel T.R. FMD vaccines. Virus Res 91 (2003) 81-99
4. McCullough K.C., and Sobrino F. Immunology of foot-and-mouth disease. In: Sobrino F., and Domingo E. (Eds). Foot and mouth disease: current perspectives (2004), Horizon Bioscience, Wymondham, UK 173-222
5. Anon. Foot-and-mouth disease (ruminants) vaccine (inactivated). European Pharmacopoeia (2008) p. 60
6. Cox S.J., Aggarwal N., Statham R.J., and Barnet P.V. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21 (2003) 1336-1347
7. Selman P, Chenard G, Dekker A. Cedivac-FMD; duration of immunity in cattle, sheep and pigs. Report of the session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease. Paphos, Cyprus; 2006, p. 215-217 [Appendix 31].
8. Office International des Epizooties (World Organisation for Animal Health). Foot and mouth disease. Terrestial animal health code. 19th ed. (2009), OIE, Paris, France [Chapter 8.5]
9. Anon. Council Directive 2003/85/EC on community measures for the control of foot-and-mouth disease repealing Directive 85/511/EEC and Decisions 89/53/EEC and 96/665/EEC and amending directive 92/46/EEC. Off J Eur Union L306 (2003)
10. Golding S.M., Hedger R.S., and Talbot P. Radial immuno-diffusion and serum neutralisation techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci 20 (1976) 142-147
11. Salt J.S., Mulcahy G., and Kitching R.P. Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of carrier and non-carrier cattle. Epidemiol Infect 117 (1996) 349-360
12. Parida S., Anderson J., Cox S.J., Barnett P.V., and Paton D.J. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine 24 (2006) 1107-1116
13. Snowdon W.A. Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells. Nature 210 (1966) 1079-1080
14. Ferris N.P., and Dawson M. Routine allocation of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. Vet Microbiol 8 (1988) 249-256
15. Cox S.J., and Barnett P.V. Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review. Vet Res 40 3 (2009) 13
16. Ugarte R. Strategy for the control of foot-and-mouth disease in Uruguay. In: Schudel A., and Lombard M. (Eds). Control of infectious animal diseases by vaccination. Developments in biologicals vol. 119 (2004), Karger, Basel 415-421
17. Barnett P.V., Statham R.J., Vosloo W., and Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21 (2003) 3240-3248
18. Brehm K.E., Kumar N., Thulke H.-H., and Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26 (2008) 1681-1687
19. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., et al. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 24 (2006) 3184-3190
20. Rweyemamu M.M., Black L., Boge A., Thorne A.C., and Terry G.M. The relationship between the 140S antigen dose in aqueous foot-and-moth disease vaccines and the serum antibody response of cattle. J Biol Stand 12 (1984) 111-120
21. Collen T., and Doel T.R. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J Gen Virol 71 (1990) 309-315